Induction of tumor PD-L1 expression likely occurs in response to inflammation induced by host antitumor immune responses [34] and through tumor-specific mutations, such as loss of the tumor-suppressor PTEN or enhanced ALK gene signaling [35, 36]. The gene discussed is ALK; the disease is neoplasm.